Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-79 (IGHV3-79), also referred to as 3-79P or IGHV379, is a member of the variable region genes of the immunoglobulin heavy chain (IGHV) locus. However, IGHV3-79 is classified as a pseudogene, meaning it does not encode a functional protein product[1][4]. The IGHV locus contains both functional variable genes important in antigen recognition (as part of antibody molecules) and a large number of pseudogenes, which are non-functional due to accumulated mutations or truncations[1][4]. As a pseudogene, IGHV3-79 does not participate in the creation of antigen-binding sites in antibodies and is not considered a therapeutic target, receptor, or drug-interaction partner. There is no current evidence for involvement in disease, utility as a biomarker, or known safety concerns for this locus. Relevant references distinguish between functional and non-functional IGHV genes, and IGHV3-79 is consistently listed among the pseudogenes[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-79 (pseudogene) (IGHV3-79).